MINOXIDIL

MINOXIDIL was reported 45341 times

MINOXIDIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ANASTOMOTIC HAEMORRHAGE 19 0.6333
1 APPLICATION SITE PLAQUE 7 0.3043
2 APPLICATION SITE ACNE 142 0.2898
3 DANDRUFF 581 0.2624
4 APPLICATION SITE DRYNESS 830 0.2443
5 HAIR INJURY 66 0.2222
6 APPLICATION SITE ULCER 155 0.2189
7 APPLICATION SITE ALOPECIA 11 0.2000
8 PERINEAL CYST 14 0.1918
9 VENA CAVA INJURY 17 0.1848
10 HYPERTRICHOSIS 295 0.1590
11 APPLICATION SITE PAPULES 165 0.1555
12 APPLICATION SITE EXFOLIATION 625 0.1516
13 PANCREATIC CYSTADENOMA 7 0.1458
14 INJECTION SITE ALOPECIA 6 0.1364
15 APPLICATION SITE PRURITUS 2979 0.1312
16 PRODUCT FORMULATION ISSUE 801 0.1213
17 APPLICATION SITE IRRITATION 1442 0.1158
18 APPLICATION SITE SCAB 246 0.1138
19 APPLICATION SITE FOLLICULITIS 8 0.1111
20 HAIR TEXTURE ABNORMAL 1428 0.1066
21 RENAL CYST HAEMORRHAGE 24 0.1062
22 ANAL CYST 6 0.1034
23 HAIR GROWTH ABNORMAL 665 0.0960
24 ADVERSE DRUG REACTION 8621 0.0959
25 APPLICATION SITE ECZEMA 8 0.0920
26 TRICHORRHEXIS 208 0.0745
27 APPLICATION SITE PARAESTHESIA 94 0.0721
28 LICHEN PLANOPILARIS 8 0.0678
29 APPLICATION SITE FISSURE 6 0.0667
30 APPLICATION SITE PAIN 1434 0.0650
31 APPLICATION SITE NODULE 8 0.0584
32 HAIR COLOUR CHANGES 715 0.0574
33 VASCULAR COMPRESSION 18 0.0570
34 APPLICATION SITE WOUND 9 0.0545
35 APPLICATION SITE INFLAMMATION 75 0.0542
36 APPLICATION SITE HYPERSENSITIVITY 65 0.0535
37 GENITAL DISORDER 7 0.0522
38 APPLICATION SITE HYPOAESTHESIA 12 0.0513
39 ABDOMINAL WALL HAEMORRHAGE 13 0.0498
40 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 15 0.0495
41 APPLICATION SITE INJURY 9 0.0474
42 DRUG ADMINISTERED AT INAPPROPRIATE SITE 500 0.0474
43 CENTRAL SEROUS CHORIORETINOPATHY 32 0.0469
44 APPLICATION SITE PUSTULES 17 0.0466
45 SEBORRHOEA 171 0.0465
46 APPLICATION SITE RASH 584 0.0424
47 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 769 0.0419
48 APPLICATION SITE INFECTION 21 0.0413
49 APPLICATION SITE DISCOMFORT 74 0.0412
50 APPLICATION SITE PERSPIRATION 7 0.0405
51 HAIR DISORDER 324 0.0393
52 APPLICATION SITE DISCHARGE 42 0.0364
53 POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME 10 0.0352
54 MIXED ANXIETY AND DEPRESSIVE DISORDER 13 0.0351
55 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 10 0.0345
56 GLOMERULONEPHRITIS ACUTE 7 0.0340
57 PRODUCT CONTAINER ISSUE 290 0.0338
58 DELAYED GRAFT FUNCTION 22 0.0309
59 APPLICATION SITE ERYTHEMA 788 0.0300
60 APPLICATION SITE WARMTH 38 0.0298
61 PRODUCT CLOSURE REMOVAL DIFFICULT 30 0.0294
62 HYPERPARATHYROIDISM SECONDARY 71 0.0283
63 ANDROGENETIC ALOPECIA 8 0.0282
64 POOR QUALITY PRODUCT ADMINISTERED 292 0.0277
65 SKIN FIBROSIS 13 0.0269
66 PENILE SIZE REDUCED 25 0.0263
67 EXPOSURE VIA EYE CONTACT 11 0.0261
68 MYOCARDIAL NECROSIS 6 0.0258
69 CONTRAINDICATED DRUG ADMINISTERED 18 0.0257
70 ALOPECIA UNIVERSALIS 7 0.0239
71 INTERVERTEBRAL DISC SPACE NARROWING 19 0.0236
72 APPLICATION SITE HAEMORRHAGE 64 0.0234
73 APPLICATION SITE VESICLES 147 0.0226
74 EAR SWELLING 46 0.0217
75 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 23 0.0217
76 CAROTID ARTERIOSCLEROSIS 22 0.0213
77 AORTIC DILATATION 23 0.0207
78 APPLICATION SITE BURN 102 0.0207
79 PNEUMONIA HAEMOPHILUS 10 0.0206
80 EXPIRED PRODUCT ADMINISTERED 678 0.0204
81 NEPHROGENIC ANAEMIA 92 0.0198
82 ALOPECIA 3835 0.0195
83 TESTICULAR PAIN 60 0.0189
84 SCROTAL OEDEMA 13 0.0183
85 RECTAL PROLAPSE 22 0.0182
86 RENAL ARTERY STENOSIS 25 0.0181
87 PRODUCT LABEL ON WRONG PRODUCT 7 0.0177
88 DARK CIRCLES UNDER EYES 26 0.0177
89 CONTRAINDICATION TO MEDICAL TREATMENT 27 0.0177
90 TESTICULAR ATROPHY 15 0.0172
91 APPLICATION SITE DERMATITIS 16 0.0171
92 PLEUROPERICARDITIS 7 0.0170
93 APPLICATION SITE REACTION 117 0.0166
94 PRODUCT PHYSICAL CONSISTENCY ISSUE 91 0.0164
95 SEBORRHOEIC DERMATITIS 27 0.0163
96 MEDICATION RESIDUE PRESENT 77 0.0161
97 MUSCULAR DYSTROPHY 7 0.0161
98 PRODUCT MONITORING ERROR 23 0.0159
99 CHEMICAL BURN 18 0.0156
100 BLADDER TRANSITIONAL CELL CARCINOMA 22 0.0154
101 SKIN WRINKLING 40 0.0147
102 LIBIDO DISORDER 19 0.0146
103 NEPHROGENIC SYSTEMIC FIBROSIS 44 0.0145
104 ARTERIOVENOUS FISTULA 7 0.0142
105 SEMEN VOLUME DECREASED 14 0.0140
106 MEIBOMIAN GLAND DYSFUNCTION 6 0.0132
107 APPLICATION SITE EROSION 17 0.0132
108 APPLICATION SITE DISCOLOURATION 51 0.0125
109 LAZINESS 21 0.0123
110 BLOOD OESTROGEN INCREASED 7 0.0119
111 AURICULAR SWELLING 7 0.0116
112 END STAGE RENAL DISEASE 205 0.0112
113 JOINT CONTRACTURE 12 0.0112
114 CARDIAC HYPERTROPHY 12 0.0108
115 PRODUCT RESIDUE PRESENT 57 0.0106
116 INTELLECTUAL DISABILITY 16 0.0105
117 SKIN TEXTURE ABNORMAL 10 0.0104
118 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 730 0.0103
119 APPLICATION SITE SWELLING 51 0.0102
120 COMPLICATIONS OF TRANSPLANTED KIDNEY 23 0.0101
121 SKIN INDURATION 21 0.0101
122 INGROWN HAIR 7 0.0101
123 HYPERTENSIVE ENCEPHALOPATHY 6 0.0101
124 PENIS DISORDER 25 0.0101
125 ACTINIC KERATOSIS 26 0.0100
126 LOSS OF LIBIDO 90 0.0100
127 NAIL DISCOLOURATION 39 0.0099
128 SEXUAL DYSFUNCTION 115 0.0098
129 APPLICATION SITE URTICARIA 22 0.0098
130 SKIN SENSITISATION 10 0.0097
131 EXTREMITY CONTRACTURE 6 0.0094
132 LEFT VENTRICULAR HYPERTROPHY 40 0.0093
133 HYPOTRICHOSIS 6 0.0093
134 VANISHING BILE DUCT SYNDROME 10 0.0090
135 MEAN CELL VOLUME INCREASED 23 0.0090
136 PRODUCT PACKAGING ISSUE 85 0.0089
137 AORTIC ARTERIOSCLEROSIS 23 0.0089
138 ERECTILE DYSFUNCTION 227 0.0088
139 GENITAL HYPOAESTHESIA 9 0.0088
140 HEPATOSPLENOMEGALY 22 0.0086
141 HYPERTENSIVE EMERGENCY 10 0.0085
142 PERIORBITAL SWELLING 48 0.0085
143 MALIGNANT HYPERTENSION 7 0.0081
144 THERAPEUTIC RESPONSE UNEXPECTED 365 0.0081
145 SWELLING OF EYELID 51 0.0081
146 RENAL TRANSPLANT FAILURE 8 0.0081
147 APPLICATION SITE SCAR 10 0.0080
148 CONTRAINDICATED PRODUCT ADMINISTERED 241 0.0080
149 SKIN HYPERTROPHY 22 0.0078
150 THERAPEUTIC PRODUCT EFFECT DELAYED 35 0.0077
151 SKIN TIGHTNESS 35 0.0074
152 CARDIAC TAMPONADE 35 0.0074
153 HYPERPARATHYROIDISM 15 0.0073
154 PRODUCT LOT NUMBER ISSUE 16 0.0072
155 DRUG ADMINISTERED IN WRONG DEVICE 7 0.0072
156 CHORIORETINOPATHY 10 0.0070
157 SKIN IRRITATION 317 0.0069
158 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1242 0.0069
159 ALOPECIA AREATA 12 0.0068
160 SCAB 78 0.0068
161 OVERDOSE 1472 0.0068
162 REBOUND ACID HYPERSECRETION 20 0.0066
163 EJACULATION FAILURE 13 0.0065
164 NIPPLE PAIN 13 0.0064
165 PERICARDIAL EFFUSION 145 0.0063
166 DRUG EFFECT INCOMPLETE 222 0.0061
167 HIRSUTISM 8 0.0060
168 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1209 0.0060
169 DRUG INEFFECTIVE 7826 0.0059
170 INCORRECT DOSE ADMINISTERED 1347 0.0059
171 AORTIC VALVE INCOMPETENCE 25 0.0059
172 HYPERTENSIVE NEPHROPATHY 6 0.0056
173 SPINAL STENOSIS 23 0.0056
174 ALLERGIC REACTION TO EXCIPIENT 11 0.0055
175 PERIORBITAL OEDEMA 27 0.0052
176 OCULAR HYPERTENSION 10 0.0051
177 EAR PRURITUS 18 0.0051
178 UNDERDOSE 372 0.0051
179 DIVERTICULUM INTESTINAL 22 0.0050
180 PRODUCT USE ISSUE 930 0.0049
181 EJACULATION DISORDER 14 0.0049
182 PRODUCT USE IN UNAPPROVED INDICATION 1206 0.0049
183 BENIGN PROSTATIC HYPERPLASIA 25 0.0048
184 MENTAL FATIGUE 7 0.0047
185 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 10 0.0045
186 PAPULE 32 0.0045
187 ACROCHORDON 6 0.0045
188 DERMAL CYST 11 0.0045
189 PRODUCT LABEL ISSUE 30 0.0044
190 INCORRECT PRODUCT ADMINISTRATION DURATION 95 0.0044
191 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 22 0.0043
192 PAIN OF SKIN 117 0.0043
193 DERMATITIS CONTACT 49 0.0043
194 FIBROSIS 13 0.0042
195 DRUG ADMINISTRATION ERROR 129 0.0042
196 CHRONIC KIDNEY DISEASE 317 0.0042
197 RENAL TRANSPLANT 15 0.0041
198 HYPERAESTHESIA 34 0.0041
199 SELF-MEDICATION 17 0.0041
200 SKIN EXFOLIATION 345 0.0041
201 BICYTOPENIA 8 0.0041
202 WRONG PATIENT RECEIVED MEDICATION 11 0.0040
203 DISTRIBUTIVE SHOCK 9 0.0040
204 SWELLING FACE 258 0.0040
205 KIDNEY TRANSPLANT REJECTION 19 0.0040
206 SKIN DISORDER 132 0.0040
207 LARGE INTESTINE POLYP 27 0.0039
208 PRODUCT PHYSICAL ISSUE 78 0.0039
209 OLIGURIA 24 0.0039
210 ESSENTIAL HYPERTENSION 7 0.0038
211 EYE SWELLING 142 0.0038
212 SQUAMOUS CELL CARCINOMA OF SKIN 23 0.0038
213 BLOOD PARATHYROID HORMONE INCREASED 11 0.0038
214 HYPERSENSITIVITY 691 0.0037
215 ATRIOVENTRICULAR BLOCK FIRST DEGREE 16 0.0037
216 RENAL FAILURE CHRONIC 28 0.0036
217 ELECTROCARDIOGRAM T WAVE INVERSION 8 0.0036
218 PRODUCT QUALITY ISSUE 487 0.0036
219 FEAR OF DEATH 8 0.0036
220 RENAL CYST 28 0.0035
221 BRAIN FOG 55 0.0035
222 HYPERTENSIVE CRISIS 39 0.0035
223 REACTION TO EXCIPIENT 8 0.0035
224 METHAEMOGLOBINAEMIA 8 0.0035
225 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 189 0.0034
226 PALPITATIONS 402 0.0034
227 BLOOD TESTOSTERONE DECREASED 23 0.0034
228 BLOOD PHOSPHORUS INCREASED 9 0.0033
229 GLOMERULONEPHRITIS 8 0.0033
230 HYPERPHOSPHATAEMIA 7 0.0033
231 AZOTAEMIA 13 0.0033
232 DRUG EFFECT LESS THAN EXPECTED 48 0.0032
233 VENTRICULAR HYPERTROPHY 8 0.0032
234 ARTERIOSCLEROSIS 30 0.0032
235 SPINAL OSTEOARTHRITIS 28 0.0032
236 ACCIDENTAL EXPOSURE TO PRODUCT 327 0.0032
237 PRODUCT PACKAGE ASSOCIATED INJURY 7 0.0031
238 INTENTIONAL PRODUCT MISUSE 272 0.0031
239 HEART RATE INCREASED 307 0.0031
240 DRUG EFFECT DELAYED 14 0.0031
241 PRODUCT PACKAGING DIFFICULT TO OPEN 8 0.0031
242 SKIN ODOUR ABNORMAL 12 0.0030
243 ANGIONEUROTIC OEDEMA 8 0.0030
244 DRUG PRESCRIBING ERROR 57 0.0030
245 BLOOD POTASSIUM INCREASED 48 0.0030
246 WRONG DRUG ADMINISTERED 26 0.0029
247 SUSPECTED OFF LABEL USE 13 0.0029
248 PORTAL VEIN THROMBOSIS 9 0.0028
249 DRY SKIN 369 0.0028
250 EYE IRRITATION 159 0.0028
251 RENAL INJURY 81 0.0027
252 SENSITIVE SKIN 20 0.0027
253 THERAPEUTIC PRODUCT EFFECT DECREASED 121 0.0027
254 SKIN REACTION 38 0.0027
255 PRURITUS 1032 0.0027
256 DERMATITIS 56 0.0027
257 FOLLICULITIS 28 0.0027
258 SKIN BURNING SENSATION 191 0.0027
259 SKIN SWELLING 23 0.0026
260 RESTLESS LEGS SYNDROME 48 0.0026
261 OFF LABEL USE 2293 0.0026
262 HAEMOLYTIC URAEMIC SYNDROME 6 0.0026
263 ATRIOVENTRICULAR BLOCK 20 0.0026
264 FLUID OVERLOAD 37 0.0025
265 SUSPECTED COUNTERFEIT PRODUCT 10 0.0025
266 CONDITION AGGRAVATED 750 0.0025
267 ACNE 187 0.0025
268 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 15 0.0025
269 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 6 0.0024
270 HEART RATE IRREGULAR 54 0.0024
271 CHEMICAL BURN OF SKIN 6 0.0024
272 TENSION HEADACHE 10 0.0023
273 PRODUCT ADMINISTRATION ERROR 47 0.0023
274 ERYTHEMA 465 0.0023
275 HORMONE LEVEL ABNORMAL 11 0.0023
276 RASH PAPULAR 50 0.0022
277 SKIN HYPERPIGMENTATION 19 0.0022
278 ANORGASMIA 6 0.0022
279 HEADACHE 1369 0.0022
280 HAEMORRHOIDS 42 0.0022
281 NEURODERMATITIS 8 0.0021
282 ROSACEA 10 0.0021
283 BREAST ENLARGEMENT 7 0.0021
284 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 152 0.0021
285 THROMBOSIS IN DEVICE 7 0.0021
286 RENAL FAILURE 282 0.0021
287 PRODUCT USE COMPLAINT 33 0.0021
288 SKIN DISCOLOURATION 96 0.0021
289 MELANOCYTIC NAEVUS 9 0.0021
290 DIALYSIS 29 0.0020
291 BLOOD PRESSURE FLUCTUATION 49 0.0020
292 BURNING SENSATION 142 0.0020
293 HAEMODIALYSIS 17 0.0020
294 BLOOD PRESSURE INADEQUATELY CONTROLLED 12 0.0020
295 ACNE CYSTIC 6 0.0020
296 VITAMIN D DECREASED 17 0.0020
297 BASAL CELL CARCINOMA 31 0.0020
298 EYELID OEDEMA 23 0.0020
299 EXPOSURE VIA SKIN CONTACT 51 0.0020
300 BRAIN NATRIURETIC PEPTIDE INCREASED 6 0.0019
301 VITREOUS FLOATERS 19 0.0019
302 EYELIDS PRURITUS 6 0.0019
303 RASH 839 0.0019
304 SUICIDAL BEHAVIOUR 8 0.0019
305 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 17 0.0019
306 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 13 0.0019
307 PRODUCT ODOUR ABNORMAL 20 0.0019
308 DERMATITIS ALLERGIC 24 0.0019
309 PRESYNCOPE 46 0.0019
310 PULMONARY HYPERTENSION 39 0.0019
311 EAR DISCOMFORT 19 0.0018
312 THERMAL BURN 13 0.0018
313 NEPHROPATHY 17 0.0018
314 BREAST MASS 12 0.0018
315 VENOUS THROMBOSIS 7 0.0018
316 CHEST PAIN 330 0.0018
317 GENERALISED OEDEMA 22 0.0018
318 DIABETIC RETINOPATHY 6 0.0018
319 PERIPHERAL VASCULAR DISORDER 9 0.0017
320 SOCIAL AVOIDANT BEHAVIOUR 10 0.0017
321 SKIN WARM 10 0.0017
322 ANHEDONIA 45 0.0017
323 UMBILICAL HERNIA 8 0.0017
324 HEAD DISCOMFORT 30 0.0017
325 ACUTE CORONARY SYNDROME 14 0.0017
326 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 12 0.0017
327 PERIPHERAL SWELLING 257 0.0017
328 DIZZINESS 828 0.0017
329 ADVERSE REACTION 22 0.0017
330 PRODUCT ADMINISTRATION INTERRUPTED 13 0.0017
331 ENTEROCOCCAL INFECTION 8 0.0017
332 RASH VESICULAR 8 0.0017
333 AFFECTIVE DISORDER 13 0.0017
334 FACIAL PARALYSIS 14 0.0016
335 JOINT RANGE OF MOTION DECREASED 22 0.0016
336 DEAFNESS UNILATERAL 9 0.0016
337 PROTEINURIA 31 0.0016
338 WEIGHT INCREASED 365 0.0016
339 TEARFULNESS 7 0.0016
340 CARDIAC FAILURE CONGESTIVE 130 0.0016
341 DIABETIC NEUROPATHY 8 0.0016
342 HEPATIC STEATOSIS 30 0.0016
343 NEPHROTIC SYNDROME 11 0.0016
344 DRUG EFFECT DECREASED 86 0.0016
345 TROPONIN INCREASED 12 0.0016
346 CONJUNCTIVAL HAEMORRHAGE 6 0.0016
347 PRODUCT COMPLAINT 39 0.0015
348 ACUTE KIDNEY INJURY 234 0.0015
349 ACUTE MYOCARDIAL INFARCTION 45 0.0015
350 PRURITUS GENERALISED 33 0.0015
351 INCORRECT PRODUCT STORAGE 20 0.0015
352 ECONOMIC PROBLEM 23 0.0015
353 BLOOD PRESSURE ABNORMAL 30 0.0015
354 HYPERPHAGIA 6 0.0015
355 ANGINA PECTORIS 43 0.0015
356 BLISTER 84 0.0015
357 PERITONITIS BACTERIAL 15 0.0015
358 FUNGAL SKIN INFECTION 6 0.0015
359 OEDEMA PERIPHERAL 180 0.0015
360 SKIN LESION 40 0.0015
361 NONSPECIFIC REACTION 8 0.0015
362 EPSTEIN-BARR VIRUS INFECTION 9 0.0014
363 HYPERTENSION 299 0.0014
364 PARAESTHESIA 222 0.0014
365 BLOOD PRESSURE INCREASED 214 0.0014
366 PANIC ATTACK 51 0.0014
367 SKIN ULCER 36 0.0014
368 SKIN ATROPHY 8 0.0014
369 INCORRECT DRUG ADMINISTRATION DURATION 39 0.0014
370 RASH PRURITIC 75 0.0014
371 MADAROSIS 16 0.0014
372 ECZEMA 72 0.0014
373 FEAR 37 0.0014
374 MIGRAINE 131 0.0014
375 SENSORY DISTURBANCE 22 0.0014
376 DYSPHEMIA 6 0.0014
377 INITIAL INSOMNIA 14 0.0014
378 FACE OEDEMA 23 0.0014
379 EYE INFLAMMATION 13 0.0014
380 HAEMATOCRIT DECREASED 27 0.0014
381 ARTERIOSCLEROSIS CORONARY ARTERY 9 0.0014
382 SECRETION DISCHARGE 17 0.0014
383 BLOOD CREATINE INCREASED 6 0.0014
384 SCAR 23 0.0013
385 POLYURIA 11 0.0013
386 IRON DEFICIENCY 6 0.0013
387 WRONG PRODUCT ADMINISTERED 9 0.0013
388 BREAST TENDERNESS 10 0.0013
389 BODY TEMPERATURE DECREASED 13 0.0013
390 PULMONARY OEDEMA 59 0.0013
391 PLEURAL EFFUSION 80 0.0013
392 HYPERKALAEMIA 46 0.0013
393 SKIN PLAQUE 11 0.0013
394 DEPRESSION 296 0.0013
395 CARDIOMEGALY 16 0.0013
396 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 22 0.0013
397 FORMICATION 9 0.0013
398 ERYTHEMA OF EYELID 7 0.0013
399 ASTHENOPIA 7 0.0013
400 PHOTOPSIA 8 0.0013
401 NASAL DISCOMFORT 10 0.0013
402 RED BLOOD CELL COUNT DECREASED 36 0.0013
403 RESTLESSNESS 46 0.0013
404 INTENTIONAL PRODUCT USE ISSUE 110 0.0013
405 HEART RATE ABNORMAL 7 0.0013
406 IMPAIRED QUALITY OF LIFE 18 0.0013
407 EYE PRURITUS 42 0.0012
408 TACHYCARDIA 111 0.0012
409 SKIN INFECTION 14 0.0012
410 VERTIGO 76 0.0012
411 PANIC REACTION 9 0.0012
412 CHEST DISCOMFORT 127 0.0012
413 FLUID RETENTION 63 0.0012
414 RASH PUSTULAR 9 0.0012
415 LIQUID PRODUCT PHYSICAL ISSUE 9 0.0012
416 FACIAL PAIN 11 0.0012
417 SWELLING 115 0.0012
418 TUBULOINTERSTITIAL NEPHRITIS 23 0.0012
419 NODULE 16 0.0012
420 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 21 0.0012
421 LACRIMATION INCREASED 37 0.0012
422 RENAL TUBULAR NECROSIS 12 0.0012
423 PHOTOPHOBIA 23 0.0012
424 PSYCHIATRIC SYMPTOM 9 0.0012
425 BREAST PAIN 13 0.0012
426 OEDEMA 66 0.0012
427 HYPERVOLAEMIA 6 0.0012
428 ABDOMINAL TENDERNESS 6 0.0012
429 ORTHOSTATIC HYPOTENSION 21 0.0012
430 ARRHYTHMIA 57 0.0012
431 SINUS TACHYCARDIA 17 0.0012
432 METABOLIC ACIDOSIS 38 0.0012
433 GLUCOSE TOLERANCE IMPAIRED 7 0.0012
434 OCULAR HYPERAEMIA 56 0.0012
435 HYPERLIPIDAEMIA 14 0.0012
436 ENDOCARDITIS 6 0.0012
437 VISION BLURRED 160 0.0012
438 TYPE 1 DIABETES MELLITUS 7 0.0012
439 ADVERSE EVENT 107 0.0012
440 ANXIETY 330 0.0012
441 OCULAR DISCOMFORT 13 0.0012
442 URTICARIA 193 0.0012
443 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
444 MYOCARDIAL ISCHAEMIA 13 0.0011
445 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
446 GROIN PAIN 10 0.0011
447 PRESCRIBED OVERDOSE 22 0.0011
448 PERICARDITIS 19 0.0011
449 RASH ERYTHEMATOUS 54 0.0011
450 ATRIAL FLUTTER 9 0.0011
451 THINKING ABNORMAL 21 0.0011
452 ACCIDENTAL OVERDOSE 41 0.0011
453 MENTAL IMPAIRMENT 27 0.0011
454 BLOOD PRESSURE DECREASED 74 0.0011
455 TINNITUS 51 0.0011
456 CEREBRAL INFARCTION 27 0.0011
457 SLEEP APNOEA SYNDROME 21 0.0011
458 MOOD ALTERED 30 0.0011
459 INTRAOCULAR PRESSURE INCREASED 14 0.0011
460 ORAL DISORDER 8 0.0011
461 HAEMOGLOBIN ABNORMAL 7 0.0011
462 CARDIAC FLUTTER 7 0.0011
463 EYELID PTOSIS 11 0.0011
464 GASTROOESOPHAGEAL REFLUX DISEASE 87 0.0011
465 ATRIAL FIBRILLATION 105 0.0011
466 ACUTE PULMONARY OEDEMA 6 0.0011
467 PRODUCT PREPARATION ISSUE 7 0.0011
468 EYE DISCHARGE 11 0.0011
469 BLOOD CREATININE INCREASED 69 0.0011
470 LIP SWELLING 35 0.0010
471 PRODUCT PRESCRIBING ERROR 25 0.0010
472 EYE PAIN 59 0.0010
473 BOWEL MOVEMENT IRREGULARITY 8 0.0010
474 CARDIAC MURMUR 9 0.0010
475 DEVICE RELATED INFECTION 16 0.0010
476 GYNAECOMASTIA 32 0.0010
477 RASH MACULAR 36 0.0010
478 URINE OUTPUT DECREASED 9 0.0010
479 EAR PAIN 20 0.0010
480 CARDIO-RESPIRATORY ARREST 43 0.0010
481 VITAMIN D DEFICIENCY 10 0.0010
482 HAEMORRHAGIC STROKE 8 0.0010
483 CORONARY ARTERY DISEASE 31 0.0010
484 HYPOAESTHESIA 153 0.0010
485 PRODUCT PREPARATION ERROR 21 0.0010
486 DEPRESSED MOOD 54 0.0010
487 DECREASED ACTIVITY 11 0.0010
488 ONYCHOCLASIS 7 0.0010
489 HYPOTENSION 204 0.0010
490 BLOOD UREA INCREASED 17 0.0010
491 GOUT 18 0.0010
492 EXTRASYSTOLES 7 0.0010
493 SWOLLEN TONGUE 31 0.0010
494 GLYCOSYLATED HAEMOGLOBIN INCREASED 25 0.0010
495 MUSCLE DISORDER 8 0.0010
496 INGUINAL HERNIA 6 0.0010
497 POST PROCEDURAL INFECTION 8 0.0010
498 PRODUCT STORAGE ERROR 86 0.0010
499 MITRAL VALVE INCOMPETENCE 11 0.0010
500 DRY EYE 48 0.0010
501 GASTROENTERITIS 14 0.0010
502 IMPAIRED GASTRIC EMPTYING 13 0.0010
503 FEELING JITTERY 18 0.0009
504 FOREIGN BODY SENSATION IN EYES 6 0.0009
505 THERAPEUTIC RESPONSE DECREASED 57 0.0009
506 SUICIDAL IDEATION 86 0.0009
507 MEDICATION ERROR 52 0.0009
508 NIGHT SWEATS 30 0.0009
509 CARDIAC DISORDER 87 0.0009
510 DYSGEUSIA 69 0.0009
511 PAROSMIA 7 0.0009
512 TENDON PAIN 7 0.0009
513 BLOOD PRESSURE SYSTOLIC INCREASED 18 0.0009
514 TARDIVE DYSKINESIA 26 0.0009
515 THERAPY CHANGE 9 0.0009
516 ASPIRATION 10 0.0009
517 PHOTOSENSITIVITY REACTION 15 0.0009
518 LUNG INFILTRATION 8 0.0009
519 APPETITE DISORDER 6 0.0009
520 APHTHOUS ULCER 7 0.0009
521 BLOOD SODIUM DECREASED 17 0.0009
522 PELVIC FRACTURE 7 0.0009
523 ATRIOVENTRICULAR BLOCK COMPLETE 6 0.0009
524 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 26 0.0009
525 DRY THROAT 9 0.0009
526 FURUNCLE 7 0.0009
527 SLUGGISHNESS 9 0.0009
528 TRICUSPID VALVE INCOMPETENCE 7 0.0009
529 RENAL IMPAIRMENT 74 0.0009
530 CARDIOMYOPATHY 13 0.0009
531 DYSPNOEA EXERTIONAL 33 0.0009
532 IMMUNODEFICIENCY 13 0.0009
533 RETINAL DETACHMENT 8 0.0009
534 SKIN FISSURES 17 0.0009
535 PERITONITIS 18 0.0009
536 VENTRICULAR EXTRASYSTOLES 9 0.0009
537 INSOMNIA 226 0.0008
538 RENAL FAILURE ACUTE 36 0.0008
539 NECK PAIN 47 0.0008
540 TENDONITIS 13 0.0008
541 POST PROCEDURAL COMPLICATION 16 0.0008
542 MENINGIOMA 13 0.0008
543 MENTAL STATUS CHANGES 23 0.0008
544 SINUS BRADYCARDIA 8 0.0008
545 APATHY 12 0.0008
546 QUALITY OF LIFE DECREASED 11 0.0008
547 HAEMOGLOBIN DECREASED 84 0.0008
548 PHARYNGEAL SWELLING 8 0.0008
549 ASCITES 24 0.0008
550 TOOTH FRACTURE 9 0.0008
551 MOOD SWINGS 26 0.0008
552 DYSURIA 30 0.0008
553 BLINDNESS TRANSIENT 6 0.0008
554 BRADYCARDIA 43 0.0008
555 NERVE INJURY 9 0.0008
556 DIPLOPIA 21 0.0008
557 CONJUNCTIVITIS 15 0.0008
558 SPEECH DISORDER 42 0.0008
559 RETCHING 17 0.0008
560 SYNCOPE 79 0.0008
561 VENTRICULAR TACHYCARDIA 13 0.0008
562 DISCOMFORT 48 0.0008
563 BLINDNESS 32 0.0008
564 NO ADVERSE EVENT 142 0.0008
565 NASAL CONGESTION 46 0.0008
566 PRODUCT DISPENSING ERROR 17 0.0008
567 MYOSITIS 7 0.0008
568 JOINT SWELLING 94 0.0008
569 ANAL INCONTINENCE 7 0.0008
570 HAEMOLYSIS 6 0.0008
571 CONCUSSION 6 0.0008
572 HIATUS HERNIA 10 0.0008
573 LIP DRY 7 0.0008
574 SUBDURAL HAEMATOMA 11 0.0008
575 ORAL HERPES 15 0.0008
576 GASTRITIS 20 0.0008
577 ANOSMIA 11 0.0008
578 BLOOD IRON DECREASED 9 0.0008
579 IRON DEFICIENCY ANAEMIA 7 0.0008
580 LETHARGY 43 0.0007
581 FEELING ABNORMAL 179 0.0007
582 LACERATION 7 0.0007
583 ABORTION INDUCED 7 0.0007
584 NOCTURIA 9 0.0007
585 DERMATITIS ATOPIC 39 0.0007
586 COLD SWEAT 13 0.0007
587 INTENTIONAL DOSE OMISSION 21 0.0007
588 COGNITIVE DISORDER 34 0.0007
589 THIRST 13 0.0007
590 JOINT STIFFNESS 19 0.0007
591 DIZZINESS POSTURAL 7 0.0007
592 AGEUSIA 18 0.0007
593 PSORIASIS 94 0.0007
594 DYSPNOEA 406 0.0007
595 EXTRA DOSE ADMINISTERED 29 0.0007
596 NEPHROPATHY TOXIC 8 0.0007
597 MUSCLE ATROPHY 9 0.0007
598 LIGAMENT SPRAIN 7 0.0007
599 HYPOTONIA 7 0.0007
600 MICTURITION URGENCY 8 0.0007
601 MYOCARDITIS 8 0.0007
602 SHOCK 16 0.0007
603 RESPIRATORY TRACT CONGESTION 11 0.0007
604 ULCER 11 0.0007
605 SUBARACHNOID HAEMORRHAGE 7 0.0007
606 C-REACTIVE PROTEIN INCREASED 25 0.0007
607 IRRITABILITY 41 0.0007
608 SLEEP DISORDER 48 0.0007
609 TEMPERATURE INTOLERANCE 7 0.0007
610 LYMPHADENOPATHY 24 0.0007
611 TENDERNESS 7 0.0007
612 FEELING HOT 41 0.0007
613 RENAL DISORDER 31 0.0007
614 DYSARTHRIA 25 0.0007
615 TACHYPNOEA 9 0.0007
616 ABDOMINAL DISTENSION 69 0.0007
617 RENAL PAIN 7 0.0007
618 FUNGAL INFECTION 22 0.0007
619 OSTEOPENIA 10 0.0007
620 DISEASE RECURRENCE 31 0.0007
621 MUSCLE TWITCHING 15 0.0007
622 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
623 CONVULSION 37 0.0006
624 THROAT IRRITATION 29 0.0006
625 EJECTION FRACTION DECREASED 10 0.0006
626 THERAPY PARTIAL RESPONDER 10 0.0006
627 OESOPHAGITIS 7 0.0006
628 FLANK PAIN 6 0.0006
629 MULTI-ORGAN FAILURE 11 0.0006
630 GASTROINTESTINAL PAIN 7 0.0006
631 SEASONAL ALLERGY 9 0.0006
632 DENTAL CARIES 7 0.0006
633 MYALGIA 107 0.0006
634 OBESITY 10 0.0006
635 MALNUTRITION 7 0.0006
636 ACUTE RESPIRATORY FAILURE 12 0.0006
637 GLAUCOMA 12 0.0006
638 LOCALISED INFECTION 15 0.0006
639 ERUCTATION 12 0.0006
640 AUTOIMMUNE DISORDER 6 0.0006
641 VISUAL IMPAIRMENT 76 0.0006
642 INTERNAL HAEMORRHAGE 7 0.0006
643 ANGIOEDEMA 27 0.0006
644 LEUKOCYTOSIS 11 0.0006
645 SKIN HAEMORRHAGE 9 0.0006
646 STAPHYLOCOCCAL INFECTION 20 0.0006
647 SINUS DISORDER 12 0.0006
648 POOR QUALITY SLEEP 13 0.0006
649 BONE DISORDER 11 0.0006
650 EAR INFECTION 16 0.0006
651 PAIN IN JAW 17 0.0006
652 COMPLETED SUICIDE 50 0.0006
653 HOT FLUSH 45 0.0006
654 APHASIA 18 0.0006
655 DISTURBANCE IN ATTENTION 32 0.0006
656 HEMIPARESIS 10 0.0006
657 MIDDLE INSOMNIA 11 0.0006
658 DRUG DISPENSING ERROR 9 0.0006
659 EUPHORIC MOOD 6 0.0006
660 PRODUCT DOSE OMISSION ISSUE 172 0.0006
661 THERAPY CESSATION 30 0.0006
662 THYROID DISORDER 9 0.0006
663 CORONARY ARTERY OCCLUSION 8 0.0006
664 UNRESPONSIVE TO STIMULI 15 0.0006
665 PROSTATIC SPECIFIC ANTIGEN INCREASED 8 0.0006
666 AGGRESSION 29 0.0006
667 EYE DISORDER 19 0.0006
668 DIVERTICULITIS 16 0.0006
669 ORAL DISCOMFORT 8 0.0006
670 POLLAKIURIA 24 0.0006
671 DEAFNESS 15 0.0006
672 KNEE ARTHROPLASTY 12 0.0006
673 HYPOXIA 20 0.0006
674 MYOCARDIAL INFARCTION 99 0.0006
675 ABNORMAL WEIGHT GAIN 7 0.0006
676 HYPERHIDROSIS 73 0.0006
677 TREATMENT NONCOMPLIANCE 31 0.0006
678 CYST 7 0.0006
679 MUSCULAR WEAKNESS 64 0.0006
680 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 27 0.0006
681 EMOTIONAL DISTRESS 68 0.0006
682 NAUSEA 443 0.0006
683 MUSCLE TIGHTNESS 9 0.0006
684 PARAESTHESIA ORAL 8 0.0006
685 THROAT TIGHTNESS 15 0.0006
686 HAEMATEMESIS 14 0.0006
687 FLUSHING 56 0.0006
688 EPISTAXIS 41 0.0005
689 THROMBOSIS 44 0.0005
690 PRODUCTIVE COUGH 26 0.0005
691 RESPIRATORY DISTRESS 15 0.0005
692 RHINORRHOEA 35 0.0005
693 COAGULOPATHY 9 0.0005
694 CONFUSIONAL STATE 87 0.0005
695 PLATELET COUNT INCREASED 7 0.0005
696 NEURALGIA 13 0.0005
697 HYPOAESTHESIA ORAL 8 0.0005
698 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
699 TOXIC EPIDERMAL NECROLYSIS 8 0.0005
700 INJURY 37 0.0005
701 ABASIA 13 0.0005
702 BLOOD ALKALINE PHOSPHATASE INCREASED 13 0.0005
703 CEREBROVASCULAR ACCIDENT 88 0.0005
704 UPPER RESPIRATORY TRACT INFECTION 24 0.0005
705 OROPHARYNGEAL PAIN 48 0.0005
706 PRODUCT TASTE ABNORMAL 7 0.0005
707 FATIGUE 402 0.0005
708 ILLNESS 53 0.0005
709 EOSINOPHILIA 9 0.0005
710 AMENORRHOEA 9 0.0005
711 CARDIOVASCULAR DISORDER 13 0.0005
712 SURGERY 30 0.0005
713 FLATULENCE 29 0.0005
714 ASTHENIA 192 0.0005
715 ANAEMIA 97 0.0005
716 VOMITING 239 0.0005
717 AMNESIA 33 0.0005
718 BACTERAEMIA 6 0.0005
719 ISCHAEMIC STROKE 9 0.0005
720 URINARY TRACT INFECTION 86 0.0005
721 TRANSIENT ISCHAEMIC ATTACK 17 0.0005
722 FEELING COLD 14 0.0005
723 GASTROINTESTINAL HAEMORRHAGE 42 0.0005
724 RESPIRATORY DISORDER 15 0.0005
725 BLOOD POTASSIUM DECREASED 15 0.0005
726 NERVOUSNESS 26 0.0005
727 ADRENAL INSUFFICIENCY 6 0.0005
728 TASTE DISORDER 10 0.0005
729 COUGH 138 0.0005
730 PANCREATITIS ACUTE 11 0.0005
731 UNEVALUABLE EVENT 37 0.0005
732 CHROMATURIA 11 0.0005
733 BLOOD GLUCOSE ABNORMAL 9 0.0005
734 MOBILITY DECREASED 35 0.0005
735 EMOTIONAL DISORDER 15 0.0005
736 OSTEOPOROSIS 20 0.0005
737 ABDOMINAL PAIN 113 0.0005
738 COVID-19 85 0.0005
739 MENTAL DISORDER 21 0.0005
740 DRY MOUTH 39 0.0005
741 DISORIENTATION 19 0.0005
742 INTENTIONAL DRUG MISUSE 10 0.0005
743 STOMATITIS 29 0.0005
744 DYSPEPSIA 47 0.0005
745 TYPE 2 DIABETES MELLITUS 16 0.0005
746 MALAISE 208 0.0005
747 ARTHRALGIA 197 0.0005
748 BLOOD CHOLESTEROL INCREASED 22 0.0005
749 INCREASED APPETITE 9 0.0005
750 WEIGHT DECREASED 131 0.0005
751 LOWER LIMB FRACTURE 9 0.0005
752 IMPAIRED WORK ABILITY 10 0.0005
753 IRRITABLE BOWEL SYNDROME 10 0.0005
754 RESPIRATORY FAILURE 34 0.0005
755 PAIN 286 0.0005
756 ANOREXIA 6 0.0005
757 RECTAL HAEMORRHAGE 20 0.0005
758 INFLAMMATION 24 0.0005
759 MUSCULOSKELETAL DISCOMFORT 8 0.0005
760 HAEMATOMA 12 0.0005
761 BRONCHITIS 34 0.0005
762 LOCAL SWELLING 8 0.0005
763 MUSCULOSKELETAL PAIN 24 0.0005
764 INSURANCE ISSUE 7 0.0005
765 BACK PAIN 106 0.0005
766 PHARYNGEAL OEDEMA 7 0.0005
767 MELAENA 10 0.0005
768 HYPOGLYCAEMIA 22 0.0005
769 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
770 LIVER DISORDER 20 0.0005
771 STEVENS-JOHNSON SYNDROME 10 0.0004
772 GENERAL PHYSICAL HEALTH DETERIORATION 52 0.0004
773 SINUSITIS 46 0.0004
774 CARDIAC ARREST 37 0.0004
775 CONSTIPATION 97 0.0004
776 FEEDING DISORDER 9 0.0004
777 GASTROENTERITIS VIRAL 8 0.0004
778 HEAD INJURY 14 0.0004
779 BALANCE DISORDER 38 0.0004
780 CARDIAC FAILURE 35 0.0004
781 AGITATION 32 0.0004
782 HIP FRACTURE 14 0.0004
783 NIGHTMARE 15 0.0004
784 SOMNOLENCE 87 0.0004
785 MASS 6 0.0004
786 CARPAL TUNNEL SYNDROME 6 0.0004
787 TREMOR 71 0.0004
788 ABDOMINAL PAIN UPPER 88 0.0004
789 OXYGEN SATURATION DECREASED 24 0.0004
790 BLOOD TEST ABNORMAL 6 0.0004
791 CHOLELITHIASIS 14 0.0004
792 OSTEOARTHRITIS 18 0.0004
793 MUSCULOSKELETAL STIFFNESS 37 0.0004
794 RESPIRATORY TRACT INFECTION 11 0.0004
795 INFECTION 61 0.0004
796 BLOOD URINE PRESENT 8 0.0004
797 HAEMORRHAGE 44 0.0004
798 LIMB DISCOMFORT 13 0.0004
799 HYPOACUSIS 18 0.0004
800 CHILLS 49 0.0004
801 PRODUCT SUBSTITUTION ISSUE 24 0.0004
802 CELLULITIS 21 0.0004
803 NERVOUS SYSTEM DISORDER 13 0.0004
804 HYPERTHYROIDISM 6 0.0004
805 MUSCLE SPASMS 76 0.0004
806 HERNIA 8 0.0004
807 DIARRHOEA 265 0.0004
808 PSYCHOTIC DISORDER 12 0.0004
809 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
810 LOSS OF CONSCIOUSNESS 52 0.0004
811 CONTUSION 39 0.0004
812 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
813 SEPSIS 45 0.0004
814 GASTROINTESTINAL DISORDER 36 0.0004
815 SNEEZING 9 0.0004
816 MEMORY IMPAIRMENT 55 0.0004
817 NEUROPATHY PERIPHERAL 38 0.0004
818 ASPARTATE AMINOTRANSFERASE INCREASED 21 0.0004
819 DEVICE FAILURE 6 0.0004
820 PAIN IN EXTREMITY 116 0.0004
821 WOUND 11 0.0004
822 NEPHROLITHIASIS 18 0.0004
823 WHITE BLOOD CELL COUNT INCREASED 15 0.0004
824 ALANINE AMINOTRANSFERASE INCREASED 24 0.0004
825 VIRAL INFECTION 13 0.0004
826 RIB FRACTURE 8 0.0004
827 ANKLE FRACTURE 6 0.0004
828 OSTEOMYELITIS 7 0.0004
829 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
830 PNEUMONIA 124 0.0004
831 HEPATIC ENZYME INCREASED 26 0.0004
832 DIABETES MELLITUS 29 0.0004
833 HAEMATURIA 13 0.0004
834 ABSCESS 6 0.0004
835 HYPOTHYROIDISM 12 0.0004
836 EATING DISORDER 8 0.0004
837 BACTERIAL INFECTION 7 0.0004
838 LACTIC ACIDOSIS 12 0.0004
839 DECREASED APPETITE 86 0.0004
840 HYPOCALCAEMIA 7 0.0004
841 FAECES DISCOLOURED 8 0.0004
842 GASTRIC ULCER 7 0.0004
843 PRODUCT PRESCRIBING ISSUE 8 0.0004
844 INJECTION SITE URTICARIA 9 0.0004
845 GAIT DISTURBANCE 70 0.0004
846 MULTIPLE FRACTURES 6 0.0004
847 INCORRECT ROUTE OF DRUG ADMINISTRATION 13 0.0004
848 CEREBRAL HAEMORRHAGE 13 0.0004
849 RESPIRATORY ARREST 10 0.0004
850 VISUAL ACUITY REDUCED 12 0.0004
851 DEHYDRATION 48 0.0004
852 WHITE BLOOD CELL COUNT DECREASED 39 0.0004
853 DYSPHONIA 21 0.0004
854 BONE PAIN 21 0.0004
855 DRUG DOSE OMISSION 59 0.0004
856 ARTHRITIS 28 0.0004
857 THERAPY NON-RESPONDER 16 0.0004
858 ABDOMINAL PAIN LOWER 9 0.0004
859 CANDIDA INFECTION 6 0.0004
860 CATARACT 21 0.0004
861 RASH GENERALISED 9 0.0003
862 ASTHMA 39 0.0003
863 BODY TEMPERATURE INCREASED 7 0.0003
864 ARTHROPATHY 19 0.0003
865 DRUG INTERACTION 54 0.0003
866 PANCYTOPENIA 19 0.0003
867 ABDOMINAL DISCOMFORT 57 0.0003
868 HOSPITALISATION 52 0.0003
869 TOOTH LOSS 7 0.0003
870 JAUNDICE 9 0.0003
871 BLOOD GLUCOSE DECREASED 16 0.0003
872 HALLUCINATION, VISUAL 7 0.0003
873 PALLOR 9 0.0003
874 JOINT INJURY 7 0.0003
875 PYREXIA 113 0.0003
876 INJECTION SITE RASH 10 0.0003
877 ANGER 11 0.0003
878 HYPOKALAEMIA 15 0.0003
879 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
880 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
881 DYSKINESIA 13 0.0003
882 INTESTINAL OBSTRUCTION 12 0.0003
883 TRANSAMINASES INCREASED 7 0.0003
884 CYSTITIS 10 0.0003
885 HYPERSOMNIA 9 0.0003
886 INJECTION SITE PRURITUS 21 0.0003
887 HEART RATE DECREASED 11 0.0003
888 GLOSSODYNIA 7 0.0003
889 HEPATITIS 8 0.0003
890 PHARMACEUTICAL PRODUCT COMPLAINT 8 0.0003
891 PRODUCT ADHESION ISSUE 11 0.0003
892 THERAPY INTERRUPTED 22 0.0003
893 BLOOD GLUCOSE INCREASED 58 0.0003
894 CHOKING 6 0.0003
895 PRODUCT AVAILABILITY ISSUE 7 0.0003
896 LUNG DISORDER 15 0.0003
897 KIDNEY INFECTION 6 0.0003
898 PULMONARY EMBOLISM 29 0.0003
899 WHEEZING 18 0.0003
900 WRONG TECHNIQUE IN DRUG USAGE PROCESS 11 0.0003
901 PANCREATITIS 16 0.0003
902 INJECTION SITE BRUISING 24 0.0003
903 INJECTION SITE SWELLING 23 0.0003
904 URINARY RETENTION 10 0.0003
905 HEPATIC FAILURE 9 0.0003
906 FREQUENT BOWEL MOVEMENTS 8 0.0003
907 DYSPHAGIA 28 0.0003
908 DIABETIC KETOACIDOSIS 7 0.0003
909 TREATMENT FAILURE 24 0.0003
910 PROCEDURAL PAIN 8 0.0003
911 RHABDOMYOLYSIS 12 0.0003
912 DEMENTIA 8 0.0003
913 WITHDRAWAL SYNDROME 12 0.0003
914 FALL 95 0.0003
915 ENCEPHALOPATHY 7 0.0003
916 TOXICITY TO VARIOUS AGENTS 48 0.0003
917 NASOPHARYNGITIS 52 0.0003
918 SYSTEMIC LUPUS ERYTHEMATOSUS 10 0.0003
919 HERPES ZOSTER 16 0.0003
920 HYPERGLYCAEMIA 10 0.0003
921 DRUG RESISTANCE 7 0.0003
922 PSORIATIC ARTHROPATHY 11 0.0003
923 URINARY INCONTINENCE 8 0.0003
924 NEOPLASM MALIGNANT 18 0.0003
925 HEPATOTOXICITY 6 0.0003
926 INFLUENZA 30 0.0003
927 COLITIS 10 0.0003
928 ROAD TRAFFIC ACCIDENT 11 0.0003
929 THROMBOCYTOPENIA 29 0.0003
930 LIMB INJURY 7 0.0003
931 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
932 COMA 12 0.0003
933 INJECTION SITE ERYTHEMA 31 0.0002
934 INTENTIONAL OVERDOSE 16 0.0002
935 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
936 HYPONATRAEMIA 14 0.0002
937 CRYING 9 0.0002
938 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7 0.0002
939 COLITIS ULCERATIVE 11 0.0002
940 LIVER INJURY 6 0.0002
941 IMPAIRED HEALING 8 0.0002
942 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
943 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
944 GAIT INABILITY 8 0.0002
945 HAEMATOCHEZIA 13 0.0002
946 PLATELET COUNT DECREASED 25 0.0002
947 GASTRIC DISORDER 8 0.0002
948 PRODUCT DOSE OMISSION 15 0.0002
949 ABNORMAL BEHAVIOUR 9 0.0002
950 FEMUR FRACTURE 7 0.0002
951 INJECTION SITE PAIN 66 0.0002
952 HAEMOPTYSIS 6 0.0002
953 VAGINAL HAEMORRHAGE 9 0.0002
954 DRUG INTOLERANCE 20 0.0002
955 SEPTIC SHOCK 9 0.0002
956 DYSSTASIA 6 0.0002
957 DISEASE PROGRESSION 24 0.0002
958 NEOPLASM PROGRESSION 7 0.0002
959 HALLUCINATION 15 0.0002
960 EPILEPSY 6 0.0002
961 BONE DENSITY DECREASED 6 0.0002
962 DEEP VEIN THROMBOSIS 12 0.0002
963 INFLUENZA LIKE ILLNESS 15 0.0002
964 SEIZURE 21 0.0002
965 LEUKOPENIA 9 0.0002
966 EXPOSURE DURING PREGNANCY 11 0.0002
967 DELIRIUM 6 0.0002
968 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 8 0.0002
969 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
970 INFUSION RELATED REACTION 11 0.0002
971 INTERSTITIAL LUNG DISEASE 8 0.0002
972 HEPATIC FUNCTION ABNORMAL 6 0.0002
973 DRUG WITHDRAWAL SYNDROME 14 0.0002
974 DEVICE MALFUNCTION 11 0.0002
975 INJECTION SITE HAEMORRHAGE 12 0.0002
976 BREAST CANCER 14 0.0002
977 DEVICE BREAKAGE 6 0.0001
978 FOETAL EXPOSURE DURING PREGNANCY 12 0.0001
979 RENAL CANCER 7 0.0001
980 ANAPHYLACTIC REACTION 8 0.0001
981 NEUTROPENIA 19 0.0001
982 DEATH 115 0.0001
983 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
984 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
985 RHEUMATOID ARTHRITIS 14 0.0001
986 DEVICE ISSUE 11 0.0001
987 PROSTATE CANCER 9 0.0001
988 ILL-DEFINED DISORDER 6 0.0001
989 FEBRILE NEUTROPENIA 6 0.0001
990 INJECTION SITE REACTION 6 0.0001
991 DRUG ABUSE 6 0.0001